% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • swhitemd50 swhitemd50 Nov 5, 2011 12:41 PM Flag


    I agree we should let the future data decide who is right on this issue. The phase 2 GT1 oral studies being run by VRUS are being matched by VRTX with their ongoing phase 2 oral studies in arms e and f of the Zenith study. Results of arms e and f of the Zenith study (all oral 400 mg VX-222/Incivek/ribavirin) study will be available in early 2012.

93.89+0.68(+0.73%)Jul 22 4:00 PMEDT